Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Endometrial Neoplasms 2Prostatic Neoplasms 1Neoplasms 1Inflammatory Breast Neoplasms 1Endometrial Hyperplasia 1Carcinoma, Ductal, Breast 1

Interventions

Letrozole 2ricin A-GnRH conjugate 1Progesterone 1Medroxyprogesterone Acetate 1LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- 1Gonadotropin-Releasing Hormone 1Cyproterone acetate, ethinyl estradiol drug combination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Endometrial Hyperplasia × Gonadotropin-Releasing Hormone × Clear all
NCT03463252 2021-09-13

Value of LNG-IUS as Fertility-preserving Treatment of EAH and EC

West China Second University Hospital

Phase 2/3 Recruiting
224 enrolled
Gynecologic

Endometrial Hyperplasia, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡